Highlights and Quick Summary
- Operating CF/Net income for the quarter ending June 30, 2023 was 0.69 (a -23.33% decrease compared to previous quarter)
- Year-over-year quarterly Operating CF/Net income decreased by -11.81%
- Annual Operating CF/Net income for 2022 was 0.81 (a -1.96% decrease from previous year)
- Annual Operating CF/Net income for 2021 was 0.83 (a -21.03% decrease from previous year)
- Annual Operating CF/Net income for 2020 was 1.05 (a 1441.97% increase from previous year)
- Twelve month Operating CF/Net income ending June 30, 2023 was 0.81 (a -1.23% decrease compared to previous quarter)
- Twelve month trailing Operating CF/Net income increased by 1.72% year-over-year
Trailing Operating CF/Net income for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| 0.81 | 0.82 | 0.81 | 0.8 |
Visit stockrow.com/DSGN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Operating CF/Net income of Design Therapeutics, Inc.
Most recent Operating CF/Net incomeof DSGN including historical data for past 10 years.Interactive Chart of Operating CF/Net income of Design Therapeutics, Inc.
Design Therapeutics, Inc. Operating CF/Net income for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 0.69 | 0.9 | – | – | – |
| 2022 | 0.87 | 0.79 | 0.7 | 0.89 | 0.81 |
| 2021 | 0.83 | 0.72 | 1.09 | 0.67 | 0.83 |
| 2020 | 0.74 | 0.8 | 0.91 | 4.01 | 1.05 |
| 2019 | – | – | – | – | 0.07 |
Business Profile of Design Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology